|
1. Black BL, Lyles DS. 1992. Vesicular stomatitis virus matrix
protein inhibits host cell-directed transcription of target genes in vivo. Journal of Virology 66:
4058-4064. 2. Black BL, Rhodes RB, McKenzie M, Lyles
DS. 1993. The role of vesicular stomatitis
virus matrix protein in inhibition of host-directed gene expression is
genetically separable from its function in virus assembly. Journal of
Virology 67: 4814-4821. 3. Black BL, Brewer G, Lyles DS. 1994. Effect of vesicular stomatitis virus
matrix protein on host directed translation in vivo. Journal of Virology 68: 555-560. 4. Black BL, Martin JF, Olson EN. 1995. The mouse MRF4 promoter is trans-activated
directly and indirectly by muscle-specific transcription factors. Journal
of Biological Chemistry 270: 2889-2892. 5. Molkentin JD, Black BL, Martin JF, Olson
EN. 1995. Cooperative
activation of muscle gene expression by MEF2 and myogenic bHLH proteins.
Cell 83: 1125-1136. 6. Molkentin JD, Black BL, Martin JF, Olson
EN. 1996. Mutational analysis of the
DNA binding, dimerization, and transcriptional activation domains of MEF2C.
Molecular and Cellular Biology 16: 2627-2636. 7. Molkentin JD, Firulli AB, Black BL,
Martin JF, Hustad CM, Copeland N, Jenkins N, Lyons G, Olson EN. 1996. MEF2B is a potent transactivator
expressed in early myogenic lineages. Molecular and Cellular Biology 16:
3814-3824. 8. Black BL, Ligon KL, Zhang Y, Olson EN.
1996. Cooperative transcriptional
activation by the neurogenic bHLH protein MASH1 and members of the MEF2
family. Journal of Biological Chemistry 271: 26659 26663. 9. Black BL, Lu J, Olson EN. 1997. The MEF2A 3« untranslated region
functions as a cis-acting
translational repressor.
Molecular and Cellular Biology 17: 2756-2763. 10. Black BL, Molkentin JD, Olson EN. 1998.
Multiple roles for the MyoD basic
region in transmission of activation signals and interaction with MEF2.
Molecular and Cellular Biology 18: 69-77. 11. Cripps RM, Black BL, Zhao B, Lien CL,
Schulz RA, Olson EN. 1998. The
myogenic regulatory gene Mef2 is a
direct target for transcriptional activation by Twist during Drosophila myogenesis. Genes and
Development 12: 422-434. 12. Black BL, Olson EN. 1998. Transcriptional control of muscle
development by myocyte enhancer factor-2 (MEF2) proteins. Annual review of cell and
Developmental Biology 14: 167-196. 13. Black BL, Olson EN. 1999. Control of
cardiac development by members of the MEF2 family of transcription factors.
In ÒHeart developmentÓ (R. P. Harvey and 14. Wilson-Rawls J, Molkentin JD, Black BL,
Olson EN. 1999. Activated Notch
inhibits myogenic activity of the MADS-box transcription factor MEF2C.
Molecular and Cellular Biology 19: 2853-2862. 15. Liu D, Black BL, Derynck R. 2001. TGF-§ inhibits muscle differentiation
through functional repression of myogenic transcription factors by Smad3. Genes and Development 15: 2950-2966. 16. Naya FJ, Black BL, Wu H, Bassel-Duby R,
17. Verzi MP, Anderson JP, Dodou E, Kelly KK,
Greene SB, North BJ, Cripps RM, Black BL. 2002. N-twist, an Evolutionarily Conserved
bHLH Protein Expressed in the Developing CNS, Functions as a Transcriptional
Inhibitor. Developmental Biology 249: 174-190. 18. Dodou E, Xu SM, Black BL. 2003. mef2c
is activated directly by myogenic basic helix-loop-helix proteins during
skeletal muscle development in vivo. Mechanisms of Development
120:1021-1032. 19. Anderson JP, Jaehnig EJ, Dodou E, Greene SB,
Olson EN, Black BL. 2004. HRC is a direct transcriptional target
of MEF2 during cardiac, skeletal, and arterial smooth muscle development in
vivo. Molecular and Cellular Biology 24: 3757-3768. 20. Dodou E, Verzi MP, 21. De Val S, 22. Stennard FA, Costa MW, Lai D, Biben C, Furtado
MB, Solloway MJ, McCulley DJ, Leimena C, Preis JI, Dunwoodie SL, Elliott DE,
Prall OWJ, Black BL, Fatkin D, Harvey RP. 2005. Murine cardiac T-box
transcription factor Tbx20 acts as a repressor during heart development in
vivo and is essential for adult heart integrity, function and adaptation.
Development 132: 2451-2462. 23. Takeuchi JK, Mileikovskaia M, Koshiba-Takeuchi
K, Heidt AB, Mori AD, Arruda EP, Gertsenstein M, Georges R, Davidson L, Mo R,
Hui CC, Henkelman RM, Nemer M, Black BL, Nagy A, Bruneau BG. 2005. Tbx20 dose-dependently regulates
transcription factor networks required for mouse heart and motor neuron
development. Development 132: 2463-2474. 24. Heidt AB, Black BL. 2005. Transgenic
mice that express Cre recombinase under control of a skeletal muscle-specific
promoter from mef2c. Genesis 42: 28-32 [Cover
Photo]. 25. Rojas A, De Val S, Heidt AB, Xu SM, Bristow J,
Black BL. 2005. Gata4 expression in lateral mesoderm is downstream of
BMP4 and is activated directly by Forkhead and GATA transcription factors
through a distal enhancer element. Development 132: 3405-3417. 26. Verzi MP, McCulley DJ, De Val S, Dodou E, Black
BL. 2005. The right ventricle, outflow tract, and
ventricular septum comprise a restricted expression domain within the
secondary/anterior heart field. Developmental Biology 287: 134-145. 27. Black BL. 2006. A
single mutation causes a spectrum of cardiovascular defects: the potential
role of genetic modifiers, epigenetic influences, and stochastic events in
phenotypic variability. Journal of Molecular and Cellular Cardiology 40:
201-204. 28.
Park EJ, Ogden LA, Talbot A, Evans S, Cai CL, Black BL, Frank DU, Moon AM. 2006. Required,
tissue-specific roles for Fgf8 in outflow tract formation and remodeling.
Development 133: 2419-2433. 29.
Ai D, Liu W, Ma L, Dong F, Lu MF, Wang D, Verzi MP, Cai C, Gage PJ, Evans S, Black BL, Brown NA, Martin JF.
2006. Pitx2 regulates cardiac left-right
asymmetry by patterning second cardiac lineage-derived myocardium.
Developmental Biology 296: 437-449. 30.
Pennacchio LA, Ahituv N, Moses AM, Prabhakar S, Nobrega MA, Shoukry M,
Minovitsky S, Dubchak I, Holt A, Lewis KD, Plajzer-Frick I, Akiyama J, De Val
S, Afzal V, Black BL, Couronne O,
Eisen MB, Visel A, Rubin EM. 2006.
In vivo enhancer analysis of
human conserved non-coding sequences. Nature 444: 499-502. 31.
Jaehnig EJ, Heidt AB, Greene SB, Cornelissen I, Black BL. 2006.
Increased susceptibility to
isoproterenol-induced cardiac hypertrophy and impaired weight gain in mice
lacking the histidine-rich calcium-binding protein. Molecular Cellular
Biology 26: 9315-9326. 32.
Black BL. 2007. Transcriptional pathways in second
heart field development. Seminars in Cell & Developmental Biology 18:
67-76. 33.
Schulz RA, Black BL. 2007. Model systems for the study of
heart development and disease.
Seminars in Cell & Developmental Biology 18: 1-2. 34.
Prall OW, Menon MK, Solloway MJ, Watanabe Y, Zaffran S, Bajolle F, Biben C,
McBride JJ, Robertson BR, Chaulet H, Stennard FA, Wise N, Schaft D, Wolstein
O, Furtado MB, Shiratori H, Chien KR, Hamada H, Black BL, Saga Y, Robertson EJ, Buckingham ME, Harvey RP.
2007. An Nkx2-5/Bmp2/Smad1 negative feedback
loop controls heart progenitor specification and proliferation. Cell 128:
947-959. 35.
Verzi MP, Agarwal P, Brown C, McCulley DJ, Schwarz JJ, Black BL. 2007. The transcription factor MEF2C is
required for craniofacial development. Developmental Cell 12: 645-652. 36.
Bruneau BG, Black BL. 2007. The heart's Da Vinci code: a
Renaissance at Keystone. Development 134: 1631-1633. 37.
Heidt AB, Rojas A, Harris IS, Black BL. 2007. Determinants of myogenic specificity
within MyoD are required for non-canonical E-Box binding. Molecular
Cellular Biology 11: in press. |